We are a group of farmers, cooks, and food professionals who couldn`t find what we wanted in the food system, so we are building it ourselves from the ground up, animal-by-animal, plant-by-plant, meal-by-meal. A truly transparent, regenerative supply chain for the future. That is our Venture, we are the Cooks.
Tata Coffee is a part of the Tata Group. Founded by Jamsetji Tata in 1868, the Tata group is a global enterprise, headquartered in India, comprising over 100 independent operating companies. The Group operates across enterprise and social sectors in 6 continents, with a mission `To improve the quality of life of the communities we serve globally, through long-term stakeholder value creation based on Leadership with Trust`.
Every day, in homes around the world, Dawn Foods helps make happiness. For almost a century, this family-owned global bakery supplier has partnered with bakers, retailers and other culinary experts to deliver the ingredients and finished baked goods for all of life`s sweet moments. Dawn Foods proudly employs more than 4,000 people in more than 70 countries and is committed to manufacturing and distributing the sweet bakery products to support customers of all sizes.
Sunwink makes super clean plant powered beverages and powders for everyday wellness. Every tonic and superfood powder is made with functional superfoods, organic natural ingredients and vetted by experts.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.